Browse studies

Find your next paid study

119 recruiting studies matching your filters

A Phase III Randomized Trial Comparing Stereotactic Body Radiation Therapy (SBRT) vs Conventional Palliative Radiation Therapy for Painful Bone Metastases

To compare increasing doses and different treatment schedules of stereotactic body radiation therapy (SBRT) against standard treatment scheduling.

Bone Metastases

Estimated

~$50 – $1,500

Actual pay is set by the research site.

M.D. Anderson Cancer CenterNCT06065449

Phase 3

A Randomized Phase III TriaL Comparing SingLe- Versus Multi-Fraction Spine STereotActic Radiosurgery for Patients With Spinal Metastases (ALL-STAR)

The goal of this study is to determine whether fractionated Stereotactic radiosurgery (SRS) for spine metastases is associated with improved local tumor contro…

Spinal Metastases

Estimated

~$50 – $1,500

Actual pay is set by the research site.

Stanford UniversityNCT06173401

Phase 2

A Multicenter, Phase II Trial of Relatlimab, Nivolumab, and Ipilimumab in Patients With Asymptomatic and Symptomatic Melanoma Brain Metastases

This is a multicenter, phase II trial of relatlimab (rela), nivolumab (nivo), and ipilimumab (ipi) in patients with asymptomatic and symptomatic melanoma brain…

MelanomaBrain Metastases

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Stanford UniversityNCT06712927

Social, Structural, and Lifestyle Drivers of Prostate Cancer Disparities

Prostate Cancer (PC) is the most common non-cutaneous malignancy diagnosed and second leading cause of cancer death among men across the United States. PC amon…

Prostate CancerProstate Cancer RecurrentProstate Metastases

Estimated

~$10 – $675

Actual pay is set by the research site.

University of California, San FranciscoNCT07690579

Development of a Clinical CEST MR Fingerprinting Method for Treatment Response Assessment in Brain Metastases

The purpose of this study is to develop and test a new magnetic resonance imaging (MRI) technique to see if it can be used to tell the difference between tumor…

Brain MetastasesBrain Metastases, AdultMetastatic Brain Tumor+1 more

Estimated

~$10 – $750

Actual pay is set by the research site.

Memorial Sloan Kettering Cancer CenterNCT05559853

Phase 3

A Phase 3, Multi-center, Randomized, Open Label Study to Evaluate the Safety and Efficacy of Abenacianine (VGT-309), a Tumor-Targeted, Activatable Fluorescent Imaging Agent, to Identify Cancer in Subjects Undergoing Surgery for Cancer in the Lung - VISUALIZE 2

This is a Phase 3, multi-center, randomized and intrasubject controlled study to evaluate the safety and efficacy of abenacianine for injection, a tumor-target…

Lung CancerLung Metastases

Estimated

~$50 – $2,100

Actual pay is set by the research site.

Vergent Bioscience, Inc.NCT07499674

Phase 1

MeFAMP for Imaging System A Amino Acid Transport in Primary and Metastatic Brain Tumors

This first-in-human study will establish the human safety and radiation dosimetry of the system A amino acid transport substrate, (R)-3-\[F-18\]fluoro-2-methyl…

Healthy VolunteersRecurrent GliomaBrain Metastases From Extra-cranial Solid Tumors

Estimated

~$500 – $7,500

Actual pay is set by the research site.

University of Alabama at BirminghamNCT05676489

Colorectal Metastasis to Liver Extraction With Auxiliary Transplant and Delayed Resection Registry Study

Liver transplantation (LT) has become an accepted treatment for selected patients with unresectable liver metastases due to colorectal cancer (CRLM). The goal …

Liver Transplant SurgeryColorectal Cancer MetastaticColon Cancer Liver Metastases

Estimated

~$10 – $750

Actual pay is set by the research site.

Northwestern UniversityNCT06698146

Phase 1

Phase 1 Trial of Engineered HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors

This study is a clinical trial to determine the safety of inoculating G207 (an experimental virus therapy) into a recurrent or refractory cerebellar brain tumo…

Neoplasms, BrainGlioblastoma MultiformeGlioblastoma of Cerebellum+30 more

Estimated

~$150 – $3,000

Phase 1

Phase 1 Trial of Trastuzumab Deruxtecan With Stereotactic Radiosurgery (SRS) in Participants With Brain Metastases From HER-2 Positive Breast Cancer

A phase I clinical trial (a type of research study) for people with human epidermal growth factor receptor 2 (HER-2) positive breast cancer with metastasis to …

Breast CancerHER2-positive Breast CancerBrain Metastases+2 more

Estimated

~$150 – $4,500

Actual pay is set by the research site.

Baptist Health South FloridaNCT07454668

Observational

PRIME-LRT: PRomoting IMmunotherapy Efficacy With Low-Dose Liver RT

The purpose of this study is to see if adding Low-Dose Liver Radiation (LD-LRT) improves progression free survival (PFS). This study is for patients with eithe…

Low-Dose Liver Radiation (LD-LRT)Non Small Cell Lung CancerMelanoma+1 more

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Jordan KharofaNCT07225036